Overexpression of N-cadherin, a biomarker associated with increased EMT [42], was observed in 83.3% (20/24) in tumor samples, while a loss of E-cadherin was seen in 95.8% (23/24) of tumor tissues. Here, CDH2 is linked to neoplasm.